Walking exercise + blood flow restriction
Walking exercise + blood flow restriction has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Aug 13, 2026: “Walking with blood flow restriction in Parkinson's disease: vascular, neurotrophic and functional outcomes: a randomized controlled trial (WALK-BFR-PD Trial)”.
1 paper studies it4 findingsUpdated
See all 1 papers on walking exercise + blood flow restriction
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“In contrast, WALK-BFR demonstrated significant improvements in BDNF and FMD (both p < 0.05)”
None of its findings points the other way.
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave walking exercise + blood flow restriction to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Increases BDNF up: Improves flow-mediated dilation up: Improves timed Up and Go test | Randomized trial8 weeks | 8 peopleParkinson's disease | European journal of applied physiology, Aug 13, 2026 |
What did studies of walking exercise + blood flow restriction find?
4Studies of walking exercise + blood flow restriction measured 4 outcomes, among them Parkinson's disease, timed Up and Go test and flow-mediated dilation.
Parkinson's disease
downin humans1
1 study
Parkinson's disease
downin humans1
Walking exercise + blood flow restriction decreases Parkinson's disease in humans (Parkinson's disease).
“and total UPDRS scores, with additional reductions in UPDRS Parts II-IV”
Human trialParkinson's disease8 weeksn = 8
European journal of applied physiology
Timed Up and Go test
upin humans1
1 study
Timed Up and Go test
upin humans1
Walking exercise + blood flow restriction improves timed Up and Go test in humans (Parkinson's disease).
“as well as functional performance (TUGT and 10MWT), quality of life (PDQ-8), and total UPDRS scores”
Human trialParkinson's disease8 weeksn = 8
European journal of applied physiology
Flow-mediated dilation
upin humans1
1 study
Flow-mediated dilation
upin humans1
Walking exercise + blood flow restriction improves flow-mediated dilation in humans (Parkinson's disease).
“In contrast, WALK-BFR demonstrated significant improvements in BDNF and FMD (both p < 0.05)”
Human trialParkinson's disease8 weeksn = 8
European journal of applied physiology
BDNF
upin humans1
1 study
BDNF
upin humans1
Walking exercise + blood flow restriction increases BDNF in humans (Parkinson's disease).
“In contrast, WALK-BFR demonstrated significant improvements in BDNF and FMD (both p < 0.05)”
Human trialParkinson's disease8 weeksn = 8
European journal of applied physiology